EUVIMEDEUVIMED entdecken
Crossref

Tear film proteome changes following Tobradex ® therapy in anterior blepharitis

Danson Vasanthan Muttuvelu iD, Lasse Jørgensen Cehofski iD, Tor Paaske Utheim, Xiangjun Chen iD, Henrik Vorum, Marie Louise Roed Rasmussen, Steffen Heegaard iD, Asif Manzoor Khan, Ahmed Basim Abduljabar, Bent Honoré

Acta Ophthalmologica · 2024

DOI: 10.1111/aos.15792 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Ophthalmologica, 2024. Verfasst von Danson Vasanthan Muttuvelu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Blepharitis, Tears, Proteome. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Fight for Sight Denmark, Synoptik-Fonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The management of blepharitis continues to challenge clinicians due to the poorly understood aetiology of the condition. We recently identified the family of intracellular plakin proteins as essential driving forces underlying anterior blepharitis. A large‐scale protein analysis was used to study if a topical dexamethasone/tobramycin solution could be used to reverse the expression of plakin proteins.

Methods

Tear film samples from treatment naïve patients with anterior blepharitis ( n = 15) were collected with Schirmer filtration paper. A subgroup of the patients ( n = 10) received treatment with a dexamethasone/tobramycin 1 + 3 mg/mL ophthalmic suspension (Tobradex ® ) for 3 weeks and collection of tear film samples was repeated. The samples were analysed with label‐free quantification nano liquid chromatography–tandem mass spectrometry requiring quantification in at least 70% of the samples in each group. Proteins were considered differentially expressed if p < 0.05.

Results

Following Tobradex ® intervention, 27 proteins were upregulated while 61 proteins were downregulated. Regulated proteins after Tobradex ® treatment were involved in intermediate filament cytoskeleton organization including downregulation of the plakin proteins envoplakin, epiplakin and periplakin. Plectin, a protein of the plakin family, remained unchanged after Tobradex ® therapy. Tobradex ® treatment resulted in the regulation of proteins involved in translation including a cluster of downregulated ribosomal proteins. Tobradex ® intervention was associated with the regulation of proteins involved in fructose metabolism and glycolytic processes including fructose‐1.6‐bisphosphatase 1, fructose‐bisphosphate aldolases A and B, pyruvate kinase PKM and transketolase. Ig lambda chain V‐I region, prominin‐1, and protein Niban were upregulated after Tobradex ® treatment.

Conclusions

Tobradex treatment reversed the expression of plakin proteins in anterior blepharitis. Topical solutions which inhibit the expression of plakin proteins may have the potential to restore the ocular surface integrity in anterior blepharitis and should be explored further.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BlepharitisTearsProteomeHumansFemaleMaleAgedMiddle AgedGlucocorticoidsDexamethasoneOphthalmic SolutionsAnti-Bacterial AgentsEye ProteinsTandem Mass SpectrometryChromatography, LiquidAdult

Stichwörter der Autor:innen

blepharitisdexamethasonemass spectrometryocular surfaceproteomeproteomicsteartearstobramycin

Substanzen

ProteomeGlucocorticoidsDexamethasoneOphthalmic SolutionsAnti-Bacterial AgentsEye Proteins

Autor:innen und Institutionen

  • Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Department of Ophthalmology, Odense University Hospital, Odense, Denmark.
  • Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.
  • The Norwegian Dry Eye Clinic, Oslo, Norway.
  • Department of Ophthalmology, Aalborg University Hospital, Aalborg, Denmark.

ORCID-Profile: Danson Vasanthan Muttuvelu, Lasse Jørgensen Cehofski, Xiangjun Chen, Steffen Heegaard

Förderung

  • Fight for Sight Denmark
  • Synoptik-Fonden

Zitieren

APA

Muttuvelu, D. V., Cehofski, L. J., Utheim, T. P., Chen, X., Vorum, H., Rasmussen, M. L. R., Heegaard, S., Khan, A. M., Abduljabar, A. B., & Honoré, B. (2024). Tear film proteome changes following Tobradex ® therapy in anterior blepharitis. Acta Ophthalmologica. https://doi.org/10.1111/aos.15792

Vancouver

Muttuvelu DV, Cehofski LJ, Utheim TP, Chen X, Vorum H, Rasmussen MLR, et al. Tear film proteome changes following Tobradex ® therapy in anterior blepharitis. Acta Ophthalmologica. 2024. doi:10.1111/aos.15792

BibTeX
@article{Muttuvelu2024,
  author = {Muttuvelu, Danson Vasanthan and Cehofski, Lasse Jørgensen and Utheim, Tor Paaske and Chen, Xiangjun and Vorum, Henrik and Rasmussen, Marie Louise Roed and Heegaard, Steffen and Khan, Asif Manzoor and Abduljabar, Ahmed Basim and Honoré, Bent},
  title = {Tear film proteome changes following Tobradex ® therapy in anterior blepharitis},
  journal = {Acta Ophthalmologica},
  year = {2024},
  doi = {10.1111/aos.15792}
}
Kostenlos starten →